Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 23 June 2000:
Vol. 288. no. 5474, pp. 2171 - 2173
DOI: 10.1126/science.288.5474.2171
Prev | Table of Contents | Next

Viewpoint

Something to Be Done: Treating HIV/AIDS

David E. Bloom, 1 River Path Associates 2

Largely because of disparities in access to drug treatment and care, AIDS morbidity and mortality have fallen in the developed world but continue to rise among developing countries. Achieving more equitable access to AIDS drugs is hindered by high drug prices, technical complexities related to the provision of health care, and conflict among stakeholders. Recognition that health is vital to the prospects of the emerging global society must be combined with new mechanisms to help all stakeholders work together cooperatively. Tiered drugs pricing should be coupled with investment in health services. An independent "Global Task Force," able to act as an "active think tank," could build consensus about the way forward.

1 Department of Population and International Health, School of Public Health, Harvard University, Boston, MA 02115, USA. E-mail: dbloom{at}hsph.harvard.edu
2 61a West Borough, Wimborne, Dorset BH 21 1LX, UK. E-mail: pathfinders{at}riverpath.com

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The AMPATH Nutritional Information System: Designing a Food Distribution Electronic Record System in Rural Kenya.
J. L. Lim, Y. Yih, C. Gichunge, W. M. Tierney, T. H. Le, J. Zhang, M. A. Lawley, T. J. Petersen, and J. J. Mamlin (2009)
J. Am. Med. Inform. Assoc. 16, 882-888
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)